SBIR/STTR Research Award
Detection of Methylation and Translocation Events by Novel Genomic Technologies
Award amount
$292,731Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BlueNovo Biosystems.com
- Proposal award date
- 2017-02-01
- Contract end date
- 2018-06-30
- UEI
- Not reported
- Solicitation number
- PA18-314
- Topic code
- NCI
Research abstract
Detection of Methylation and Translocation Events by Novel Sequencing Technology
ABSTRACTThe rapid development of DNA sequencing technologies advanced our understanding of the molecular
basis of cancerHowevercancer genomics involves very complex molecular rearrangementssuch as
translocationsrequiring the investigation of long DNA molecules with single nucleotide discriminationCurrent
Next Generation SequencingNGStechnologies cannot address such performance requirements and face
challenging limitationsThe long term goal of this proposal is to develop a rapid and highly accurate DNA sequencing system
that has the potential to fully control the speed and orientation at which the DNA passes through an electronic
detectorsolid stateboth in forwardreadingand reverseproof readdirectionsIn contrast with other
nanopore technologiesour technology decouples the feeding step from the reading stepenabling to
sequence full genomes starting with minute quantity of materialCombinedthe characteristics have the
potential to provide our sequencing technology with the capability to achieve single nucleotide discrimination
with an accuracy ofor higher using long DNA moleculeskbSuch a system is anticipated to be
capable of accurately reading such long fragments of DNA starting from minute quantities of material without
the need of amplificationThis would provide both practitioners and cancer researchers with a much better
tool than the current state of the art sequencing technologiesIndeed we project that our technology will
enable the collection of information of genetic and epigenetic markers of cancer both in expressed and non
expressed areas of the genome while reaching time and cost performance metrics currently unachieved on
the marketThe goal of the current PhaseRproposal is to demonstrate that by incorporating our proprietary
technology into a sequencing systemwe will be able to detect important molecular changes that are
associated with cancer initiation and proliferationto include long range methylations and translocations as
well as chromoplexySuch detection will be rendered possible due to the ability of our system to fully control
the translocation rate and linearization of the DNA while passing through the sequencing system detectorIn Phase IIRwill focus on the incorporation of an embedded solid stateelectronicnanoelectrode detection component to the initial system developed in phase I for single base nucleotide readingProvided that targeted milestones are achievedcommercial development of a prototype instrument along
with associated consumable chips and reagents will be initiated immediately following the completion of
phase IIWe project that our technology has the potential to sequence a full human genome in less than one
hour at the cost of $from biopsy materialthus reaching performance metrics currently unavailable on the
current marketand providing cancer researchers and medical practitioners with an invaluable affordable tool
for the elucidation of molecular mechanisms of cancer and the detection of specific molecular changes which
may improve early clinical detection of the disease Narrative
The potential of high accuracy sequencing of long DNA moleculesbpsfor cancer
research and clinical diagnostics applications is well recognized by the scientific and medical
communityThe ability to map methylation and long range translocation events with a high
degree of accuracy will significantly contribute to advancements in the field of cancer
diagnostics especially if such sequencing can be performed with single base resolutionat a
cost of less than $within minutesTo datethe best technologies for genome
mapping sequencing have failed to satisfy the demand for accuracyspeedcostand long DNA
fragments which is essential for translocation event detection
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis